Eupraxia Pharmaceuticals raised a round of funding on December 21, 2012.
Eupraxia Pharmaceuticals is a clinical stage pharmaceutical company targeting the most prevalent diseases in the western world. The company builds next-generation drugs that increase efficacy, duratio…
